Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 257

Similar articles for PubMed (Select 14990586)

1.

A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein.

Tang J, Wu S, Liu H, Stratt R, Barak OG, Shiekhattar R, Picketts DJ, Yang X.

J Biol Chem. 2004 May 7;279(19):20369-77. Epub 2004 Feb 27.

2.

The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies.

Xue Y, Gibbons R, Yan Z, Yang D, McDowell TL, Sechi S, Qin J, Zhou S, Higgs D, Wang W.

Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10635-40. Epub 2003 Sep 2.

3.
4.

Patient mutations alter ATRX targeting to PML nuclear bodies.

Bérubé NG, Healy J, Medina CF, Wu S, Hodgson T, Jagla M, Picketts DJ.

Eur J Hum Genet. 2008 Feb;16(2):192-201. Epub 2007 Oct 24.

5.

Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4.

Chang CC, Lin DY, Fang HI, Chen RH, Shih HM.

J Biol Chem. 2005 Mar 18;280(11):10164-73. Epub 2005 Jan 6.

6.

Control of human adenovirus type 5 gene expression by cellular Daxx/ATRX chromatin-associated complexes.

Schreiner S, Bürck C, Glass M, Groitl P, Wimmer P, Kinkley S, Mund A, Everett RD, Dobner T.

Nucleic Acids Res. 2013 Apr 1;41(6):3532-50. doi: 10.1093/nar/gkt064. Epub 2013 Feb 8.

7.

Physical and functional interactions between Daxx and TSG101.

Muromoto R, Sugiyama K, Yamamoto T, Oritani K, Shimoda K, Matsuda T.

Biochem Biophys Res Commun. 2004 Apr 9;316(3):827-33.

PMID:
15033475
8.

Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.

Lin DY, Huang YS, Jeng JC, Kuo HY, Chang CC, Chao TT, Ho CC, Chen YC, Lin TP, Fang HI, Hung CC, Suen CS, Hwang MJ, Chang KS, Maul GG, Shih HM.

Mol Cell. 2006 Nov 3;24(3):341-54.

9.

Single-cell analysis of Daxx and ATRX-dependent transcriptional repression.

Newhart A, Rafalska-Metcalf IU, Yang T, Negorev DG, Janicki SM.

J Cell Sci. 2012 Nov 15;125(Pt 22):5489-501. doi: 10.1242/jcs.110148. Epub 2012 Sep 12.

10.

A conserved truncated isoform of the ATR-X syndrome protein lacking the SWI/SNF-homology domain.

Garrick D, Samara V, McDowell TL, Smith AJ, Dobbie L, Higgs DR, Gibbons RJ.

Gene. 2004 Feb 4;326:23-34.

PMID:
14729260
12.
13.
14.

EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription.

Tsai K, Thikmyanova N, Wojcechowskyj JA, Delecluse HJ, Lieberman PM.

PLoS Pathog. 2011 Nov;7(11):e1002376. doi: 10.1371/journal.ppat.1002376. Epub 2011 Nov 10.

15.

EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.

Li R, Pei H, Watson DK, Papas TS.

Oncogene. 2000 Feb 10;19(6):745-53.

16.

Sequestration and inhibition of Daxx-mediated transcriptional repression by PML.

Li H, Leo C, Zhu J, Wu X, O'Neil J, Park EJ, Chen JD.

Mol Cell Biol. 2000 Mar;20(5):1784-96.

17.

PML NBs (ND10) and Daxx: from nuclear structure to protein function.

Lindsay CR, Morozov VM, Ishov AM.

Front Biosci. 2008 May 1;13:7132-42. Review.

PMID:
18508722
18.

Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres.

Lewis PW, Elsaesser SJ, Noh KM, Stadler SC, Allis CD.

Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14075-80. doi: 10.1073/pnas.1008850107. Epub 2010 Jul 22.

20.

Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.

Lehembre F, Müller S, Pandolfi PP, Dejean A.

Oncogene. 2001 Jan 4;20(1):1-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk